Literature DB >> 21620477

Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers.

Fadi T Maalouf1, David Brent, Luke Clark, Lucy Tavitian, Rebecca Munnell McHugh, Barbara J Sahakian, Mary L Phillips.   

Abstract

BACKGROUND: Current treatment outcomes of Major Depressive Disorder (MDD) in adolescents remain suboptimal. Discriminating between state and trait markers of MDD in adolescents would help identify markers that may guide choice of appropriate interventions and help improve longer-term outcome for individuals with the illness.
METHODS: We compared neurocognitive performance in executive function, sustained attention and short-term memory in 20 adolescents with MDD in acute episode (MDDa), 20 previously depressed adolescents in remission (MDDr) and 17 healthy control participants (HC).
RESULTS: There was a group difference that emerged for executive function with increasing task difficulty (p=0.033). MDDa showed impaired executive function, as measured by using more moves to solve 4-move problems on a forward planning task, relative to MDDr and HC (p=0.01, d=0.94 and p=0.015, d=0.77 respectively). MDDa showed more impulsivity as measured by lower response bias (B″) on a sustained attention task than both MDDr and HC (p=0.01, d=0.85 and p=0.008, d=0.49 respectively). Higher impulsivity was associated with more severe depression (r=-0.365, p=0.022) and earlier age of onset of depression (r=0.402, p=0.012) and there was a trend for a correlation between more executive dysfunction and more severe depression (r=0.301 p=0.059) in MDDa and MDDr combined. The three groups did not differ significantly on short-term memory or target detection on the sustained attention task. LIMITATION: These results need to be replicated in the future with a larger sample size.
CONCLUSION: Executive dysfunction and impulsivity appear to be state-specific markers of MDD in adolescents that are related to depression severity and not present in remission.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21620477      PMCID: PMC4119611          DOI: 10.1016/j.jad.2011.04.041

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  54 in total

Review 1.  Adult clinical neuropsychology: lessons from studies of the frontal lobes.

Authors:  Donald T Stuss; Brian Levine
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

2.  Selected executive skills in adolescents with recent first episode major depression.

Authors:  Zoë A Kyte; Ian M Goodyer; Barbara J Sahakian
Journal:  J Child Psychol Psychiatry       Date:  2005-09       Impact factor: 8.982

3.  Identifying cognitive problems in children and adolescents with depression using computerized neuropsychological testing.

Authors:  Brian L Brooks; Grant L Iverson; Elisabeth M S Sherman; Marie-Claude Roberge
Journal:  Appl Neuropsychol       Date:  2010-01

4.  Cognitive impairment in the euthymic phase of chronic unipolar depression.

Authors:  S Paradiso; G J Lamberty; M J Garvey; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1997-12       Impact factor: 2.254

5.  Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.

Authors:  Greg J Siegle; Wesley Thompson; Cameron S Carter; Stuart R Steinhauer; Michael E Thase
Journal:  Biol Psychiatry       Date:  2006-10-06       Impact factor: 13.382

Review 6.  Neurocognitive mechanisms in depression: implications for treatment.

Authors:  Luke Clark; Samuel R Chamberlain; Barbara J Sahakian
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

7.  Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

Authors:  David Brent; Graham Emslie; Greg Clarke; Karen Dineen Wagner; Joan Rosenbaum Asarnow; Marty Keller; Benedetto Vitiello; Louise Ritz; Satish Iyengar; Kaleab Abebe; Boris Birmaher; Neal Ryan; Betsy Kennard; Carroll Hughes; Lynn DeBar; James McCracken; Michael Strober; Robert Suddath; Anthony Spirito; Henrietta Leonard; Nadine Melhem; Giovanna Porta; Matthew Onorato; Jamie Zelazny
Journal:  JAMA       Date:  2008-02-27       Impact factor: 56.272

8.  Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm.

Authors:  Asa Hammar; Lin Sørensen; Guro Ardal; Ketil Joachim Oedegaard; Rune Kroken; Atle Roness; Anders Lund
Journal:  Scand J Psychol       Date:  2009-12-23

9.  A self-report measure of pubertal status: Reliability, validity, and initial norms.

Authors:  A C Petersen; L Crockett; M Richards; A Boxer
Journal:  J Youth Adolesc       Date:  1988-04

10.  Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression.

Authors:  Joana V Taylor Tavares; Luke Clark; Dara M Cannon; Kristine Erickson; Wayne C Drevets; Barbara J Sahakian
Journal:  Biol Psychiatry       Date:  2007-09-07       Impact factor: 13.382

View more
  27 in total

1.  Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study.

Authors:  Fadi T Maalouf; Giovanna Porta; Benedetto Vitiello; Graham Emslie; Taryn Mayes; Gregory Clarke; Karen D Wagner; Joan Rosenbaum Asarnow; Anthony Spirito; Martin Keller; Boris Birmaher; Neal Ryan; Wael Shamseddeen; Satish Iyengar; David Brent
Journal:  J Affect Disord       Date:  2012-01-30       Impact factor: 4.839

Review 2.  Executive function and attention in children and adolescents with depressive disorders: a systematic review.

Authors:  Veronika Vilgis; Timothy J Silk; Alasdair Vance
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-30       Impact factor: 4.785

3.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 4.  A meta-analysis of cognitive functions in children and adolescents with major depressive disorder.

Authors:  Stefanie Wagner; Carmen Müller; Isabella Helmreich; Michael Huss; André Tadić
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-29       Impact factor: 4.785

5.  Preschool Executive Control and Internalizing Symptoms in Elementary School.

Authors:  Timothy D Nelson; Katherine M Kidwell; Jennifer Mize Nelson; Cara C Tomaso; Maren Hankey; Kimberly Andrews Espy
Journal:  J Abnorm Child Psychol       Date:  2018-10

6.  Neurocognitive Functioning in Depressed Young People: A Systematic Review and Meta-Analysis.

Authors:  Joanne Goodall; Caroline Fisher; Sarah Hetrick; Lisa Phillips; Emma M Parrish; Kelly Allott
Journal:  Neuropsychol Rev       Date:  2018-04-22       Impact factor: 7.444

7.  Milnacipran enhances the control of impulsive action by activating D₁-like receptors in the infralimbic cortex.

Authors:  Iku Tsutsui-Kimura; Yu Ohmura; Takeshi Izumi; Haruko Kumamoto; Taku Yamaguchi; Takayuki Yoshida; Mitsuhiro Yoshioka
Journal:  Psychopharmacology (Berl)       Date:  2012-08-15       Impact factor: 4.530

8.  Associations Among Symptoms of Autism, Symptoms of Depression and Executive Functions in Children with High-Functioning Autism: A 2 Year Follow-Up Study.

Authors:  Per Normann Andersen; Erik Winther Skogli; Kjell Tore Hovik; Jens Egeland; Merete Øie
Journal:  J Autism Dev Disord       Date:  2015-08

9.  INFLEXIBLE COGNITION PREDICTS FIRST ONSET OF MAJOR DEPRESSIVE EPISODES IN ADOLESCENCE.

Authors:  Jonathan P Stange; Samantha L Connolly; Taylor A Burke; Jessica L Hamilton; Elissa J Hamlat; Lyn Y Abramson; Lauren B Alloy
Journal:  Depress Anxiety       Date:  2016-04-19       Impact factor: 6.505

10.  Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men.

Authors:  Sean R Womack; Daniel S Shaw; Chelsea M Weaver; Erika E Forbes
Journal:  J Stud Alcohol Drugs       Date:  2016-03       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.